CNTN2 and adult T-cell leukemia/lymphoma: This novel combination of assays revealed that most of the Tax‐specific CTLs maintained in aggressive ATLL patients with long‐term survival and CR on intensive chemotherapy with or without mogamulizumab treatment were memory CTLs.